Noriko Tanaka

703 total citations
22 papers, 556 citations indexed

About

Noriko Tanaka is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Noriko Tanaka has authored 22 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Noriko Tanaka's work include Angiogenesis and VEGF in Cancer (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Noriko Tanaka is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Noriko Tanaka collaborates with scholars based in Japan, United States and Germany. Noriko Tanaka's co-authors include Y Osada, Michio Iwahana, Hitoshi Ogawa, Akiko Tohgo, Shizuo Kadoya, M Nakano, Yumi Matsuzaki, Shinsaku Sakurada, S. Zaki Salahuddin and Richard L. Gallo and has published in prestigious journals such as Science, JNCI Journal of the National Cancer Institute and Journal of Cellular Physiology.

In The Last Decade

Noriko Tanaka

20 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noriko Tanaka Japan 13 308 153 132 107 78 22 556
Claus Fittschen United States 9 271 0.9× 147 1.0× 74 0.6× 219 2.0× 53 0.7× 18 586
Nibedita Chattopadhyay India 12 349 1.1× 147 1.0× 89 0.7× 175 1.6× 112 1.4× 22 572
K Mafune Japan 14 367 1.2× 147 1.0× 103 0.8× 79 0.7× 57 0.7× 28 698
Udaya Yerramalla United States 8 315 1.0× 86 0.6× 157 1.2× 131 1.2× 72 0.9× 10 634
Fumie Omotehara Japan 17 454 1.5× 253 1.7× 197 1.5× 34 0.3× 55 0.7× 32 769
H Egami Japan 15 309 1.0× 272 1.8× 149 1.1× 31 0.3× 52 0.7× 27 690
Marian Rocha Germany 12 205 0.7× 167 1.1× 65 0.5× 38 0.4× 28 0.4× 18 627
Nektaria Simiantonaki Germany 13 296 1.0× 476 3.1× 169 1.3× 39 0.4× 40 0.5× 24 836
C. Sheehan Canada 9 364 1.2× 328 2.1× 150 1.1× 38 0.4× 64 0.8× 9 818
Jeannette Bourguignon France 15 425 1.4× 110 0.7× 102 0.8× 67 0.6× 184 2.4× 25 604

Countries citing papers authored by Noriko Tanaka

Since Specialization
Citations

This map shows the geographic impact of Noriko Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Tanaka more than expected).

Fields of papers citing papers by Noriko Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Tanaka. The network helps show where Noriko Tanaka may publish in the future.

Co-authorship network of co-authors of Noriko Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Noriko Tanaka. A scholar is included among the top collaborators of Noriko Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriko Tanaka. Noriko Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Kondo, Seiji, Noriko Tanaka, Satoshi Kubota, et al.. (2006). Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells. Molecular Cancer Therapeutics. 5(1). 129–137. 20 indexed citations
5.
Takeda, Yasuyuki, Kouichi Uoto, Michio Iwahana, et al.. (2004). New highly active taxoids from 9β-dihydrobaccatin-9,10-acetals. Part 5. Bioorganic & Medicinal Chemistry Letters. 14(12). 3209–3215. 2 indexed citations
6.
Takeda, Yasuyuki, Kouichi Uoto, Michio Iwahana, et al.. (2004). New Highly Active Taxoids from 9β‐Dihydrobaccatin‐9,10‐acetals. Part 5. ChemInform. 35(41). 1 indexed citations
7.
Takeda, Yasuyuki, Toshiharu Yoshino, Kouichi Uoto, et al.. (2003). New highly active taxoids from 9β-dihydrobaccatin-9,10-acetals. Part 3. Bioorganic & Medicinal Chemistry Letters. 13(2). 185–190. 17 indexed citations
8.
Aonuma, Masashi, Michio Iwahana, Yutaka Nakayama, et al.. (1998). Tumorigenicity depends on angiogenic potential of tumor cells: dominant role of vascular endothelial growth factor and/or fibroblast growth factors produced by tumor cells. Angiogenesis. 2(1). 57–66. 10 indexed citations
9.
Iwahana, Michio, Yutaka Nakayama, Noriko Tanaka, Masanobu GORYO, & Kōsuke Okada. (1996). Quantification of tumour‐induced angiogenesis by image analysis. International Journal of Experimental Pathology. 77(3). 109–114. 12 indexed citations
10.
Nakayama, Yutaka, et al.. (1993). Inhibitory effects of a bacteria‐derived sulfated polysaccharide against basic fibroblast growth factor‐induced endothelial cell growth and chemotaxis. Journal of Cellular Physiology. 154(1). 1–6. 19 indexed citations
11.
Nakamura, Shuji, Shinsaku Sakurada, S. Zaki Salahuddin, et al.. (1992). Inhibition of Development of Kaposi's Sarcoma-Related Lesions by a Bacterial Cell Wall Complex. Science. 255(5050). 1437–1440. 61 indexed citations
12.
Iwahana, Michio, et al.. (1991). Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2.. PubMed. 51(3). 903–6. 133 indexed citations
13.
Tanaka, Noriko, et al.. (1991). The Combination of a Bacterial Polysaccharide and Tamoxifen Inhibits Angiogenesis and Tumour Growth. International Journal of Radiation Biology. 60(1-2). 79–83. 25 indexed citations
14.
Matsuzaki, Yumi, et al.. (1990). Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.. PubMed. 85(1). 15–23. 57 indexed citations
15.
Tohgo, Akiko, Noriko Tanaka, Hirokazu Okada, & Y Osada. (1989). Effect of Combined Intrapleural Administration of Lactobacillus casei (LC9018) and Adriamycin on Experimental Malignant Pleurisy in Mice. Japanese Journal of Cancer Research. 80(12). 1238–1245. 3 indexed citations
16.
Tanaka, Noriko, et al.. (1989). Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid.. PubMed. 49(23). 6727–30. 50 indexed citations
17.
18.
Sakamoto, Naoko, Noriko Tanaka, Akiko Tohgo, Y Osada, & Hitoshi Ogawa. (1987). Inhibitory Effects of Heparin Plus Cortisone Acetate on Endothelial Cell Growth Both in Cultures and in Tumor Masses. JNCI Journal of the National Cancer Institute. 78(3). 581–5. 26 indexed citations
19.
Tohgo, Akiko, Noriko Tanaka, Shinji Ashida, & Hiroki Ogawa. (1984). Platelet-aggregating activities of metastasizing tumor cells. II. Variety of the aggregation mechanisms.. PubMed. 4(3). 134–45. 22 indexed citations
20.
Kohga, Shin, et al.. (1981). Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis.. PubMed. 41(11 Pt 1). 4710–4. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claus Fittschen Breakdown of academic impact, for papers by Nibedita Chattopadhyay Breakdown of academic impact, for papers by K Mafune Breakdown of academic impact, for papers by Udaya Yerramalla Breakdown of academic impact, for papers by Fumie Omotehara Breakdown of academic impact, for papers by H Egami Breakdown of academic impact, for papers by Marian Rocha Breakdown of academic impact, for papers by Nektaria Simiantonaki Breakdown of academic impact, for papers by C. Sheehan Breakdown of academic impact, for papers by Jeannette Bourguignon
Rankless by CCL
2026